BusinessPharma Stocks to Watch Ahead of Q2 Results
Pharma companies may benefit from rupee depreciation in Q2, especially exporters, despite risks from high freight and input costs. InCred anticipates potential pressure on Dr Reddy’s, Divi’s, Lupin, Cipla, Torrent Pharma, and Blue Jet Healthcare. The report highlights top stock picks in the pharmaceutical sector for the upcoming quarter.
Mint Markets·


